Liawatidewi Yakob 4
4 · Amphastar Pharmaceuticals, Inc. · Filed Nov 8, 2024
Insider Transaction Report
Form 4
Liawatidewi Yakob
DirectorEVP CORP ADMIN CENTER
Transactions
- Exercise/Conversion
Common Stock
2024-11-06$13.03/sh+5,214$67,938→ 80,152 total - Sale
Common Stock
2024-11-06$52.05/sh−5,214$271,389→ 74,938 total - Exercise/Conversion
Employee Stock Option (right to buy)
2024-11-06−5,214→ 10,962 totalExercise: $13.03Exp: 2030-03-16→ Common Stock (5,214 underlying)
Holdings
- 2,459(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023..
- [F2]The reported shares are held of record by the Yakob and Sunmoon Trust dated July 25, 2013 for which the reporting person serves as a trustee.
- [F3]Shares subject to the option are fully vested and immediately exercisable.